Rush Eye Associates
Amarillo, Texas, 79106, United States
NCT Number: NCT04903301
To evaluate patient reported outcomes associated with quality of vision before and after treatment with Contoura Vision Topography-Guided LASIK.
Looking for future studies?
Notify Me21 year–35 year
All sexes
Interventional
Not applicable
Amarillo, Texas, 79106, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Eligibility criteria: The study enrollment will include all willing patients with: pre-operative BCVA 20/20 for each eye individually, myopic refractive error up to -8.00 diopters, refractive astigmatism that ranges from 0 to 3 diopters, maximum spherical equivalent of -9.00 diopters, the designated age requirements, and only patients that have signed the informed consent document.
Exclusion criteria
Patients are excluded that are not willing to participate in a research trial, are unable to cooperate well enough to safely perform the procedure, fail to meet inclusion criteria, have ocular disease (including but not limited to keratoconus, macular degeneration, glaucoma, corneal dystrophy, dry eye syndrome and corneal scarring), and patients that have had previous ocular surgery. Any patients with known allergies to the post-operative medications or preservatives in the medications will also be excluded.
Topography-Guided LASIK using Phorcides Analytic Software
Time frame: 26 weeks
Analog Score from Adapted from PROWL Survey
Time frame: 26 weeks
Uncorrected Visual Acuity using ETDRS
Time frame: 26 weeks
HD Analyzer
Time frame: 26 weeks
Galilei Topography
Rush Eye Associates
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT04200898
Astigmatism, Eye Diseases
Zagreb, City of Zagreb, Croatia
View Trial DetailsNCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT05740293
Astigmatism, Eye Diseases
Fayetteville, Arkansas, United States
View Trial Details